North America:

  • Meta invests in Scale AI, potentially avoiding regulatory review but facing competition scrutiny, and appoints Arun Srinivas as head in India.
  • Eli Lilly expands access to its weight-loss drug Zepbound through LillyDirect with fixed monthly pricing.
  • Intercontinental Exchange Inc. dual-lists on NYSE Texas.
  • RTX Corp's Pratt & Whitney secures contracts for Leidos' missile program and GTF engines for Frontier Airlines' Airbus A321neo aircraft.
  • Omnicom faces a $13.25 billion merger investigation with Interpublic by the UK's CMA.
  • Air Canada faces challenges after a plane crash and technical issues with its Dreamliner fleet, prompting calls for enhanced safety measures.

Europe:

  • Airbus secures significant orders, including 27 A321neo and A321XLR from ANA Holdings and a $3.5 billion deal with Saudi Arabia's AviLease.
  • Kering shares rise 9.4% as Luca de Meo is set to replace Francois-Henri Pinault as CEO.
  • TotalEnergies acquires a 25% interest in Chevron-operated offshore blocks in the Gulf of Mexico and expands in Malaysia.
  • Eaton Corporation PLC acquires Ultra PCS Limited for $1.55 billion to strengthen its aerospace market position.
  • Knowit secures a 2.7 billion SEK framework agreement with Finnish DVV and CEO purchases 1500 shares.
  • Roche pauses Elevidys development due to liver failures and advances prasinezumab into phase 3 trials for Parkinson's.

Rest of the world:

  • Santos receives an $18.7 billion takeover offer from an ADNOC-led consortium.
  • ASX Ltd under ASIC investigation for governance and risk management, shares drop 4.3%.
  • Scandinavian Astor Group acquires Ammunity, while Santos supports ADNOC's takeover bid.
  • Bega Cheese seeks ACCC approval to acquire Fonterra's Oceania business.